I agree that this site is using cookies. You can find further informations here.
X
Pockros, Paul J.
171  results:
Search for persons X
?
1

SAT-047 Racial disparities in the receipt of liver transpla..:

Chehade, Nabil El Hage ; Nguyen, Isabelle ; Chehade, Nour El Hage...
Journal of Hepatology.  80 (2024)  - p. S384-S385 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Safety, tolerability, and efficacy of maralixibat in adults..:

Bowlus, Christopher L. ; Eksteen, Bertus ; Cheung, Angela C....
Hepatology Communications.  7 (2023)  6 - p. , 2023
Link: https://doi.org/10.1097/..
 
?
3

A Novel Tissue Atlas and Online Tool for the Interrogation ..:

Alsop, Eric ; Meechoovet, Bessie ; Kitchen, Robert...
Frontiers in Cell and Developmental Biology.  10 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
4

Review article: a treatment algorithm for patients with chr..:

Dieterich, Douglas T. ; Bernstein, David ; Flamm, Steven..
Alimentary Pharmacology & Therapeutics.  , 2020
Link: https://doi.org/10.1111/..
 
?
5

Efficacy and Safety of Cenicriviroc in Patients With Primar..:

Eksteen, Bertus ; Bowlus, Christopher L. ; Montano‐Loza, Aldo J....
Hepatology Communications.  5 (2020)  3 - p. 478-490 , 2020
Link: https://doi.org/10.1002/..
 
?
6

Mo1471 – Three Years of Obeticholic Acid Therapy Results in..:

Bowlus, Christopher L. ; Pockros, Paul J. ; Kremer, Andreas E....
Gastroenterology.  156 (2019)  6 - p. S-1318 , 2019
Link: https://doi.org/10.1016/..
 
?
7

A Randomized, Controlled, Phase 2 Study of Maralixibat in t..:

Mayo, Marlyn J. ; Pockros, Paul J. ; Jones, David...
Hepatology Communications.  3 (2019)  3 - p. 365-381 , 2019
Link: https://doi.org/10.1002/..
 
?
8

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in..:

Lawitz, Eric ; Gane, Edward ; Cohen, Eric...
Kidney International Reports.  4 (2019)  2 - p. 257-266 , 2019
Link: https://doi.org/10.1016/..
 
?
9

Practical strategies for pruritus management in the obetich..:

Pate, Jennifer ; Gutierrez, Juilo A ; Frenette, Catherine T...
BMJ Open Gastroenterology.  6 (2019)  1 - p. e000256 , 2019
Link: https://doi.org/10.1136/..
 
?
10

Efficacy and safety of ombitasvir/paritaprevir/ritonavir an..:

Poordad, Fred ; Sedghi, Shahriar ; Pockros, Paul J....
Journal of Viral Hepatitis.  26 (2019)  8 - p. 1027-1030 , 2019
Link: https://doi.org/10.1111/..
 
?
11

FRI-033-Long-term obeticholic acid treatment is associated ..:

Kremer, Andreas E ; Bowlus, Christopher ; Bedossa, Pierre...
Journal of Hepatology.  70 (2019)  1 - p. e398 , 2019
Link: https://doi.org/10.1016/..
 
?
12

761 – Long-Term Obeticholic Acid Treatment is Associated wi..:

Kremer, Andreas E. ; Bowlus, Christopher L. ; Bedossa, Pierre...
Gastroenterology.  156 (2019)  6 - p. S-1211 , 2019
Link: https://doi.org/10.1016/..
 
?
13

The Benefit of Direct-Acting Antiviral HCV Cure Therapies:

, In: Topics in Medicinal Chemistry; HCV: The Journey from Discovery to a Cure,
Pockros, Paul J. - p. 429-445 , 2019
Link: https://doi.org/10.1007/..
 
?
14

CONTROL: A randomized phase 2 study of obeticholic acid and..:

Pockros, Paul J. ; Fuchs, Michael ; Freilich, Bradley...
Liver International.  39 (2019)  11 - p. 2082-2093 , 2019
Link: https://doi.org/10.1111/..
 
?
15

Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or ..:

Bernstein, David E. ; Tran, Albert ; Martin, Paul...
Kidney International Reports.  4 (2019)  2 - p. 245-256 , 2019
Link: https://doi.org/10.1016/..
 
1-15